USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $-1.28 | $-1.21 | $-1.13 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $23.36M | $23.57M | $15.45M |
Deciphera Pharmaceuticals, Inc's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 10 | $-1.30 | $-1.46 | $-1.19 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 10 | $-4.85 | $-5.06 | $-4.69 |
| Dec 2022 | 10 | $-4.00 | $-5.14 | $-2.90 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 2 / 0 | $-1.32 | $-1.32 | $-1.16 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 1 / 1 | $-4.86 | $-4.86 | $-4.53 |
| Dec 2022 | 1 / 1 | $-3.84 | $-3.84 | $-3.25 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 10 | $24.18M | $21.80M | $29.00M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 10 | $96.39M | $91.98M | $103.50M |
| Dec 2022 | 10 | $177.02M | $112.46M | $258.50M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $-1.28 | - | - |
| Aug 3, 2021 | Jun 2021 | $-1.16 | $-1.21 | -4.73% |
| May 4, 2021 | Mar 2021 | $-1.10 | $-1.06 | 3.53% |
| Feb 9, 2021 | Dec 2020 | $-1.18 | $-1.10 | 6.98% |
| Nov 5, 2020 | Sep 2020 | $-1.31 | $-1.13 | 13.85% |
| Aug 4, 2020 | Jun 2020 | $-1.39 | $-1.20 | 13.94% |
| May 5, 2020 | Mar 2020 | $-1.28 | $-1.36 | -6.37% |
| Mar 9, 2020 | Dec 2019 | $-1.22 | $-1.31 | -7.81% |
| Nov 4, 2019 | Sep 2019 | $-1.16 | $-1.28 | -10.56% |
| Aug 2, 2019 | Jun 2019 | $-1.06 | $-0.56 | 47.10% |
| May 9, 2019 | Mar 2019 | $-0.88 | $-1.25 | -42.58% |
| Mar 14, 2019 | Dec 2018 | $-0.72 | $-0.86 | -19.66% |
| Nov 8, 2018 | Sep 2018 | $-0.65 | $-0.65 | 0.55% |
| Aug 7, 2018 | Jun 2018 | $-0.67 | $-0.65 | 2.93% |
| May 8, 2018 | Mar 2018 | $-0.65 | $-0.66 | -1.95% |
| Mar 28, 2018 | Dec 2017 | $-0.44 | $-0.62 | -42.46% |
| Nov 14, 2017 | Sep 2017 | $-0.61 | $-0.49 | 19.65% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 9, 2021 | Dec 2020 | $-4.84 | $-4.79 | - |
| Mar 9, 2020 | Dec 2019 | $-4.17 | $-4.40 | - |
| Mar 14, 2019 | Dec 2018 | $-2.68 | $-2.82 | - |
| Mar 28, 2018 | Dec 2017 | $-2.88 | $-1.11 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $23.36M | - | - |
| Aug 3, 2021 | Jun 2021 | $23.57M | $23.57M | 1.00% |
| May 4, 2021 | Mar 2021 | $22.59M | $25.16M | 1.11% |
| Feb 9, 2021 | Dec 2020 | $18.93M | $19.49M | 1.03% |
| Nov 5, 2020 | Sep 2020 | $7.05M | $15.45M | 2.19% |
| Aug 4, 2020 | Jun 2020 | $890.00K | $7.09M | 7.97% |
| May 5, 2020 | Mar 2020 | $210.00K | $62.00K | 0.30% |
| Mar 9, 2020 | Dec 2019 | $1.15M | $0.00 | - |
| Nov 4, 2019 | Sep 2019 | $500.00K | $0.00 | - |
| Aug 2, 2019 | Jun 2019 | $2.00M | $25.00M | 12.50% |
| May 9, 2019 | Mar 2019 | $0.00 | $0.00 | - |
| Mar 14, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Nov 8, 2018 | Sep 2018 | $0.00 | $0.00 | - |
| Aug 7, 2018 | Jun 2018 | $0.00 | $0.00 | - |
| May 8, 2018 | Mar 2018 | $0.00 | $0.00 | - |
| Mar 28, 2018 | Dec 2017 | $0.00 | $0.00 | - |
| Nov 14, 2017 | Sep 2017 | - | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 9, 2021 | Dec 2020 | $41.43M | $42.09M | 1.59% |
| Mar 9, 2020 | Dec 2019 | $26.25M | $25.00M | -4.76% |
| Mar 14, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Mar 28, 2018 | Dec 2017 | $0.00 | $0.00 | - |
DCPH's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 10 analysts, the average EPS estimation for Deciphera Pharmaceuticals, Inc's next quarterly earnings is $-1.28, with a low EPS estimation of $-1.37, and a high estimation of $-1.20.
Over the last 1 month, EPS estimates have seen 1 upward revisions and 1 downward. The EPS 1 month trend is $-1.27, the last 2 month trend is $-1.27, and the 3 month trend is $-1.16.
Based on 9 analysts, the average revenue estimation is $23.36M, with a low revenue estimation of $21.29M, and a high estimation of $25.70M.
Deciphera Pharmaceuticals, Inc's previous earnings date was Aug 3, 2021 for its fiscal quarter ended Jun 30, 2021.
DCPH's earnings per share (EPS) was $-1.21, missing the consensus analysts forecast of $-1.16 by -4.73%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by 14.15%, and lower than the same period a year before (Jun 2020) by 0.83%.
Revenues were $23.57M, better than the forecast of $23.57M by 0.00%, down by -6.29% from the previous quarter , and up by 232.48% from the same period last year.
The company reported a net income of $-70.43M.Free cash flow for the quarter was $-52.40M , compared to $-68.32M last quarter and $-63.83M a year before.
DCPH ended the quarter with $30.46M in total debt, a decrease of -1.69% compared to the previous quarter, and an increase of 82.33% compared to the same quarter a year before.
Deciphera Pharmaceuticals, Inc's previous annual earnings date was Feb 9, 2021 for its fiscal year ended Dec 31, 2020.
DCPH's earnings per share (EPS) was $-4.79, beating the consensus analysts forecast of $-4.84 by -1.03% , and lower than the previous year's EPS (Dec 2019) by 8.86%.
Revenues were $42.09M, better than the forecast of $41.43M by 1.59%, and up by 68.35% from previous year's revenue.
The company reported a net income of $-266.49M.
Deciphera Pharmaceuticals, Inc reported a free cash flow of $-245.00M for its fiscal year, compared to $-154.23M a year ago.
The company ended the fiscal year with $31.22M in total debt, an increase of 76.88% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.